Biweekly menopausal substitutive hormone therapy: effects on climacteric and prevention of osteoporosis
Zylberberg, B.; Dormont, D.
Contraception Fertilite Sexualite 24(12): 874-878
1996
ISSN/ISBN: 1165-1083 PMID: 9026274 Document Number: 456228
Document emailed within 1 workday
Related Documents
Taleghany, P. 1971: Cyclic hormone therapy in climacteric and menopausal women in Iran. Report of 600 cases International Surgery 56(2): 78-81Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Chaopotong, P.; Titapant, V.; Boriboonhirunsarn, D. 2005: Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok Journal of the Medical Association of Thailand 88(12): 1768-1774
Villaseca, P.; Arteaga, E.; Campusano, C.; López, J.M.; Rojas, A.; Nazar, G.; O'Brien, A. 1996: Effects of hormone replacement therapy in bone resorption, in post-menopausal women Revista Medica de Chile 124(12): 1439-1446
Lamy, O.; Krieg, M-Antoine. 2002: Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis Revue Medicale de la Suisse Romande 122(8): 377-381
Van der Mooren, M.J.; Merkus, J.M. 1996: Favorable effects of menopausal hormone substitution therapy on risk factors for ischemic heart disease Nederlands Tijdschrift Voor Geneeskunde 140(25): 1328-1329
Inanir, A.; Ozoran, K.; Tutkak, H.; Mermerci, B. 2004: The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis Journal of International Medical Research 32(6): 570-582
Osmanağaoğlu, M.A.; Karahan, S.C.; Aran, T.; Güven, S.; Cora, A.; Kopuz, M.; Bozkaya, H. 2013: The effects of hormone therapy on ischemia modified albumin and soluble CD40 ligand levels in obese surgical menopausal women Clinical and Experimental Obstetrics and Gynecology 40(3): 389-392
Oliaro, A. 1998: Raloxifene: a new molecule for the prevention of menopausal osteoporosis Minerva Ginecologica 50(3): XII-XIII
Horowitz, M.; Need, A.G.; Morris, H.A.; Nordin, B.E. 1991: Post menopausal osteoporosis. Part 2: Treatment and prevention Australian Family Physician 20(5): 675-680
Notelovitz, M. 1986: Post-menopausal osteoporosis. A practical approach to its prevention Acta Obstetricia et Gynecologica Scandinavica. Supplement 134: 67-80
Hegenscheid, K.; Schmidt, C.O.; Seipel, R.; Laqua, R.é; Ohlinger, R.; Hosten, N.; Puls, R. 2012: Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy European Radiology 22(12): 2633-2640
Agnusdei, D.; Zacchei, F.; Bigazzi, S.; Cepollaro, C.; Nardi, P.; Montagnani, M.; Gennari, C. 1989: Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis Drugs under Experimental and Clinical Research 15(2): 97-104
Donát, J.; Havel, V.; Hanousek, L. 1983: Vaginal hormone cytology in the therapy of climacteric and postcastration syndrome Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 26(2): 123-129
Chittacharoen, A.; Domhardt, R.; Manonai, J.; Theppisai, U.; Golbs, S. 2004: Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy Journal of the Medical Association of Thailand 87(1): 1-7
Magnusson, C.; Persson, I. 1997: Hormone therapy in climacteric. Varying research results on risks and benefits Lakartidningen 94(13): 1176-1179
Lobo, R.A.; Bélisle, S.; Creasman, W.T.; Frankel, N.R.; Goodman, N.F.; Hall, J.E.; Ivey, S.L.; Kingsberg, S.; Langer, R.; Lehman, R.; McArthur, D.B.; Montgomery-Rice, V.; Notelovitz, M.; Packin, G.S.; Rebar, R.W.; Rousseau, M.; Schenken, R.S.; Schneider, D.L.; Sherif, K.; Wysocki, S. 2006: Should symptomatic menopausal women be offered hormone therapy? Medgenmed: Medscape General Medicine 8(3): 40
Regestein, Q.R.; Friebely, J.; Shifren, J.; Schiff, I. 2001: Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement Journal of Women's Health and Gender-Based Medicine 10(7): 671-676
Scharla, S.H. 1999: Therapy of osteoporosis: native vitamin D or as hormone? Advantages of activated vitamin D in secondary osteoporosis MMW Fortschritte der Medizin 141(31-32): 32-36
Saranyaratana, W.; Sakondhavat, C.; Silaruks, S.; Soontrapa, S.; Kaewrudee, S. 2006: Effect of hormone therapy on lipid profile in menopausal women Journal of the Medical Association of Thailand 89(Suppl 4): S37-S41